Core Scientific Inc. Tranche 2 Warrants (CORZZ)
StalwartFairStock Score: 27/100 — RISKY
Key Financials
| Current Price | $15.34 |
| Market Cap | — |
| P/E Ratio | — |
| ROE | —% |
| Dividend Yield | —% |
| Sector | Financial Services |
Strengths
- Superior net profit margin of 60.9% indicating pricing power and operational efficiency
Concerns
- Revenue declining at 16.0% year-over-year signals potential demand weakness or market share loss
AI Analysis
Core Scientific Inc. Tranche 2 Warrants is a micro-cap financial services company. The business generates $355 million in annual revenue with a 60.9% net margin and $175 million in free cash flow. Growth dynamics show revenue growing at -16.0% and profit growth of 180.7%. Our composite FairStock Score of 27/100 reflects below-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the financial services space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer